Details of the Drug

General Information of Drug (ID: DMUI7WV)

Drug Name

XBIO-101

Synonyms

sodium cridanimod; cridanimod; Cridanimod; 38609-97-1; 9-Oxo-10(9H)-acridineacetic acid; 10-Carboxymethyl-9-acridanone; N-(Carboxymethyl)acridone; (9-oxoacridin-10(9H)-yl)acetic acid; 10(9H)-ACRIDINEACETIC ACID, 9-OXO-; Cridanimod [INN]; 2-(9-oxoacridin-10(9H)-yl)acetic acid; (9-Oxo-9H-acridin-10-yl)-acetic acid; UNII-X91E9EME19; 10-Carboxymeth-9-acridanone; Cycloferon; BRN 0227508; 9-Oxo-10-acridanacetic acid; X91E9EME19; C15H11NO3; Cridanimod (INN); 2-(9-oxoacridin-10-yl)acetic acid; 10(9H)-Acridineaceticacid, 9-oxo-; (9-Oxo-10(9H)-acrid

Indication

Disease Entry	ICD 11	Status	REF
Endometrial cancer	2C76	Phase 2	[1]
Malignant uterine tumour	2C76.Z	Phase 2	[2]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C15H11NO3
Canonical SMILES: C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3N2CC(=O)O
InChI: 1S/C15H11NO3/c17-14(18)9-16-12-7-3-1-5-10(12)15(19)11-6-2-4-8-13(11)16/h1-8H,9H2,(H,17,18)
InChIKey: UOMKBIIXHQIERR-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 38072
ChEBI ID: CHEBI:136036
CAS Number: 38609-97-1
TTD ID: D0OS6P

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)